MMP2 and breast cancer: According to research about the effects of oral EGCG administration on patients with breast cancer receiving radiation therapy, EGCG decreased the activation of MMP2 and MMP9 in patient sera and decreased serum levels of VEGF and hepatocyte growth factor (HGF) in comparison to patients who were not receiving treatment [91].